Firefly, Sprinter Team Up to Close the Loop on Virtual Primary Care
MedCity News
NOVEMBER 10, 2022
Sprinter Health is integrating its at-home clinical and diagnostic services into Firefly Health’s virtual primary care model.
clinical eye-care 
How retailers and “payviders” are disrupting U.S. healthcare in 2024
Clarivate
APRIL 18, 2024
Amazon’s big splash happened in February 2023 when it purchased the national primary-care practice One Medical for $3.9 One Medical offers a membership-based virtual and in-person care model. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.
Retail 
52
52 Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Oculis SA and EBAC join to drive ophthalmology innovation
pharmaphorum
OCTOBER 18, 2022
Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye care with breakthrough innovations, is to combine with the European Biotech Acquisition Corp (EBAC), a special purpose acquisition company (SPAC) that has screened over 100 European biotechnology companies.
Biopharma 59
59 
iHealthScreen Inc. Announces FDA 510K Submission for iPredict™ AMD tool
Legacy MEDSearch
MAY 24, 2023
iPredict TM AI Eye Screening System provides fully automated age-related macular degeneration (AMD) screening, including retinal imaging and immediate reporting of actionable results. K192113) in both primary care and eye care settings. an ophthalmologist). an ophthalmologist).
FDA 52
52 
MHRA warns of serious eye-related adverse events after Dupixent use
Pharmaceutical Technology
DECEMBER 7, 2022
On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.
Side effects 64
64 
Your HCP marketing just became harder, a lot harder
World of DTC Marketing
JUNE 11, 2021
Key Points: Trust in the CDC and FDA has decreased dramatically during the COVID-19 pandemic among health care professionals, according to a new WebMD/Medscape poll. Trust is essential to build relationships, but in the eyes of many HCPs, the trust has been broken during and now after the pandemic with the approval of Biogen’s drug.
Marketing 187
187 
Episode 70 – In the C-Suite with Patricia Zilliox, CEO, Eyevensys
Medical Device Success
NOVEMBER 14, 2021
Today’s guest is Patricia Zilliox, CEO of Eyevensys, a clinical stage biotechnology company based in Paris, France and Dallas, Texas. Instead, they turn a little muscle in the eye into a protein factory. Today’s guest is Patricia Zilliox, CEO of Eyevensys, a clinical stage biotechnology company based in Paris, France and Dallas, Texas.
Transportation 130
130 
Realising the vision of value-based healthcare in cataract surgery
pharmaphorum
NOVEMBER 15, 2022
Value-based healthcare (VBHC) is gaining traction across the industry for its potential to improve patient care by standardising clinical and patient outcomes. The procedure, in which a surgeon replaces a cloudy lens in the eye with an artificial one to improve a person’s sight, is widely considered safe and effective.
Healthcare 52
52 
The Animal Health Portal: A Veterinary Lifesaver
Celeritas
NOVEMBER 30, 2022
The demand for and willingness to spend on extensive care, pet health plans, etc. However, two of the greatest concerns in the veterinary field are the understaffing of veterinarian clinics and the lack of urgent care available to pets as a result. are also on the rise. Features of an Animal Health Portal.
Prescription 98
98 
Oculis enters merger deal with European Biotech Acquisition
Pharmaceutical Technology
OCTOBER 18, 2022
Oculis works on developing product candidates for areas with substantial medical needs, including diabetic macular oedema (DME), dry eye disease (DED) and glaucoma. The portfolio of the company comprises three clinical-stage product candidates, namely OCS-01, OCS-02 and OCS-05.
Streamlining Center of Excellence Provider Network Development in Record Time
Clarify Health
SEPTEMBER 29, 2023
With an eye toward curbing healthcare costs while improving quality, many organizations are investing in Centers of Excellence (CoEs). They often play a critical role in advancing medical knowledge and improving patient care in specialized areas of healthcare.
Networking 52
52 
Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology
Legacy MEDSearch
OCTOBER 20, 2022
a global artificial intelligence (AI) digital health company and the leader in real-world applications for AI Eye Screening and AI Predictive Biomarkers , announced it has secured $26 million in a Series A financing round, bringing the Company’s total funding to over $43 million. Eyenuk, Inc., Eyenuk, Inc.
Healthcare 52
52 
Type 2 diabetes is a national health emergency
World of DTC Marketing
MARCH 29, 2022
The clinical trial proved that a half-hour of walking or other low-intensity activities daily, combined with a low-fat diet, reduced the risk of developing type 2 diabetes by 58 percent. In addition, low physical activity levels are associated with $117 billion in health care costs every year. What is the role of healthcare?
Insurance 231
231 
KFA-115 by Novartis for Melanoma: Likelihood of Approval
Pharmaceutical Technology
FEBRUARY 28, 2023
KFA-115 is under clinical development by Novartis and currently in Phase I for Melanoma. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Prescription 68
68 
Théa Open Innovation signs licence deal with Galimedix
Pharmaceutical Technology
MARCH 30, 2023
It is currently ready to enter Phase II/III clinical trials. The company will completely fund GAL-101’s remaining development in dry AMD and will also be responsible for the registration and commercialisation of the drug, while Galimedix will handle the mid-stage clinical trials.
Sales 52
52 
Four ways Biogen is tackling digital innovation in neurological disease
pharmaphorum
DECEMBER 11, 2022
“We have a collaboration using artificial intelligence in an MS Lesion Analyser, developing classifiers to better detect and understand the MS evolution from an MRI perspective, even before the clinical symptoms set in,” Hadjiat said. Hadjiat says it will be a continuum of care. “We AI gets us closer to personalised medicine.”.
Patients 130
130 
Six ways AI can help providers drive transformation in healthcare
Clarify Health
FEBRUARY 27, 2024
The use of AI in healthcare can streamline administrative processes One of the most pivotal improvements providers can make is improving operational efficiency by streamlining administrative processes that impact the cost and overall quality of patient care.
Healthcare 52
52 
Enhancing Patient Care: 4 Strategies for Life Sciences Companies
Salesforce
FEBRUARY 20, 2024
Angulo’s daughter, Vera, was born with a rare disease called Sturge Weber Syndrome that caused the blood vessels to form improperly on her face, in her right eye, and in her brain, leading to complications such as epilepsy. Sturge Weber Syndrome is extremely rare and there are so many unknowns.
Patients 137
137 
Paychecks with Purpose: How Compensation is Changing in Medical Sales
Contrarian Sales Techniques
OCTOBER 31, 2023
It's about understanding the needs of providers, offering solutions, and being a trusted partner in patient care. The focus is shifting from just selling a product to ensuring that the product aligns with patient needs, improves health outcomes, and enhances the quality of care. It's all about recognizing and rewarding genuine value.
KFA-115 by Novartis for Malignant Mesothelioma: Likelihood of Approval
Pharmaceutical Technology
FEBRUARY 28, 2023
KFA-115 is under clinical development by Novartis and currently in Phase I for Malignant Mesothelioma. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Prescription 40
40 
How the food allergy sector is benefitting from health tech’s recent boom
pharmaphorum
OCTOBER 10, 2022
Previously, there were frequent pushbacks to telemedicine, owing to concerns over privacy and quality of care. Food allergy tech innovators now have access to third-party customisable tools for electronic health records, clinical support, billing, and prescribing. The recent growth of health tech. About the author.
Food 102
102 
Lilly preps for rollout of its connected diabetes system
pharmaphorum
NOVEMBER 8, 2022
Taken together, the system can support patients with medication reminders, education resources, insulin dose logging and feedback on blood glucose levels, while a hub for physicians called Tempo Insights to help them make decisions about patient care based on data. The system works as follows.
Management 64
64 
AbbVie acquires DJS for $255m cash, fortifies immunology pipeline
pharmaphorum
OCTOBER 21, 2022
DJS’ co-founders, David Llewellyn and Joe Illingworth said: “DJS was built on the principles of scientific curiosity and an aspiration to discover clinically meaningful innovative medicines. In addition to immunology, AbbVie’s other therapeutic research areas include oncology, neuroscience, eye care, virology, and gastroenterology.
Side effects 59
59 
Rentschler Biopharma and Ikarovec partner to expedite new gene therapies
Pharmaceutical Technology
JUNE 2, 2023
The AAV material will be used for the planned pre-clinical testing of the new gene therapy of Ikarovec to treat geographic atrophy, an advanced form of age-related macular degeneration that may result in the progressive and irreversible destruction of retinal tissue. Topic sponsors are not involved in the creation of editorial content.
Biopharma 52
52 
Iptacopan hydrochloride by Novartis for Paroxysmal Nocturnal Hemoglobinuria: Likelihood of Approval
Pharmaceutical Technology
FEBRUARY 28, 2023
Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase III for Paroxysmal Nocturnal Hemoglobinuria. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Prescription 40
40 Iptacopan hydrochloride by Novartis for Glomerulonephritis: Likelihood of Approval
Pharmaceutical Technology
FEBRUARY 28, 2023
Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase III for Glomerulonephritis. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Prescription 40
40 
A Pet Owner’s Guide to Understanding Leptospirosis in Dogs
Celeritas
SEPTEMBER 5, 2022
You may also notice a yellowing of the skin, eyes and mouth, etc. jaundice-like state of yellowed eyes and skin, as previously mentioned. The clinic will likely be able to identify the issue quickly and act to save your dog’s life. This disease has multiple impacts on a dog’s liver system. which is similar to jaundice.
Side effects 98
98 
ililli: How Social Audio is Driving HCP Engagement
Pharma Marketing Network
JANUARY 19, 2022
We say ililli like EYE-lily. The biggest eye care meeting of the year, the American Academy of Ophthalmology (AAO), was coming up. Based on their experiences and standing as social mavens of eye care, Drs. Must be kismet. Or iKismet. So, we talked to doctors about talking on ililli during the AAO. We’ll take it.
Doctors 97
97 
ASRS conference reveals hopeful outcomes for gene therapy RGX-314 in retinal diseases
Pharmaceutical Technology
JULY 22, 2022
Clinical trial results in DR patients have shown that 47% of eyes treated with RGX-314 have experienced diabetic retinopathy severity score (DRSS) improvements of two or more steps. The post ASRS conference reveals hopeful outcomes for gene therapy RGX-314 in retinal diseases appeared first on Pharmaceutical Technology.
Patients 104
104 
Tapping into pharma’s growing opportunities in digital health
Pharmaceutical Technology
AUGUST 4, 2022
Smarter diagnostic tools and more sophisticated remote- and self-care models will have an increasingly important role to play, as long as any advances are seen to deliver excellent outcomes and a better patient experience. Marcos Gallego Llorente, senior consultant, Vintura. Doing more for patients with chronic conditions.
How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?
Nixon Gwilt Law
APRIL 22, 2024
Appropriate: Guarantees that DSIs are suitable for the contexts and populations in which they are used, adhering to relevant clinical and ethical standards. Effective: Ensures that DSIs achieve their intended outcomes, improving clinical decision-making and patient care.
Healthcare 52
52 
Samsara Vision Announces First U.S. Surgeries of the SING IMT™ (Smaller-Incision New-Generation Implantable Miniature Telescope), for Age-Related Macular Degeneration as part of the CONCERTO Study
Legacy MEDSearch
JULY 11, 2022
surgeries of its SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope), as part of the CONCERTO clinical study, a U.S.-based In addition, candidates cannot have had previous cataract surgery in the study eye and must agree to post-operative comprehensive visual rehabilitation and training.
Closing the Gaps in Telehealth
Impetus Digital
OCTOBER 19, 2022
Here is a sneak peek of our conversation: Q: There’s a lot of discussion about not enough health care spaces and the home becoming the new hospital. It was taken out of the home and moved into large institutions like hospital systems, not because it was better clinically, but because it was more efficient.
Top 10 Best Telemedicine Companies in the USA
Medico Reach
FEBRUARY 17, 2023
Teladoc Health was formed by the principle of “Everybody should have access to the best medical care, wherever they are in the world” By offering whole-person virtual care, which encompasses primary care, chronic disease management, and more, they are now fulfilling their purpose.
Doctors 40
40 
Health System Diversification Trends
Clarify Health
JUNE 9, 2023
Patients are becoming smarter consumers of their health and at greater price transparency , leading them away from the acute setting to more outpatient lower cost settings of care. ASC investments proved worthwhile in fending off the continued encroachment of free-standing clinics.
Physicians 52
52 
Patient adherence – the key to restoring trust in pharma
pharmaphorum
JANUARY 31, 2023
Another factor that impacts trust in pharmaceutical companies is the discrepancy between the efficacy of medications in controlled clinical trials and their effectiveness in real-world use. This feeling contributes to a deep mistrust in both specific branded medications and the pharmaceutical industry producing those medications.
Patients 52
52 
The Legacy MEDSearch Layoff Survival Guide
Legacy MEDSearch
JANUARY 20, 2023
If you are being laid off, focus on taking care of business. Look at your resume with fresh eyes, and always ask for help! Stay calm and focused. It can be hard to stay calm in an overwhelming and unexpected situation, like being laid off, but it is important to do so. Remember, keep your cool. Stay positive!
Recruitment 96
96 
Age-related macular degeneration market expected to grow to $22.8bn in 2031
Pharmaceutical Technology
JULY 28, 2022
Lower frequency of administration represents a significant alleviation of treatment burden and lower cost of treatment compared with standard of care. The therapy received FDA approval in October last year. A one-time treatment option would represent a significant shift in the treatment burden for wAMD.
Marketing 52
52 
Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More
PM360
SEPTEMBER 21, 2023
A wave of blockbuster generic drugs launches, new brand drugs that address unmet needs, and legislation that would bring transparency to the pharmacy benefit manager (PBM) industry are just some of the developments that managed care pharmacy leaders are watching closely this year. billion in sales. “The billion in sales.
Management 105
105 
Eylea data gives Regeneron/Bayer a lift in ophthalmic diseases
pharmaphorum
SEPTEMBER 9, 2022
A higher dose of Regeneron and Bayer’s Eylea given every three or four months has shown efficacy in a pair of clinical trials, in a big boost for the multibillion-dollar product.
Consulting 52
52 
How To Use Nursing Experience to Land a Job in Medical Sales
Medical Sales News
MAY 27, 2021
At Medical Sales College, we have helped countless nurses and others who come from a clinical background land their dream job in medical sales. Experience in a clinical setting – understanding of clinical dynamics. Giving mentality – patient care and wanting to make a change. Experience in a clinical setting.
The Vital Role of Caregiver Communications: A Caregiver’s Perspective
PM360
SEPTEMBER 7, 2023
In the blink of an eye, my mother went from an independent super-senior to one completely dependent on me. Caregiving has reached crisis proportions in American healthcare, where cradle-to-grave care is no longer guaranteed. million 1 Americans provided unpaid care to an adult over 50—nearly 17% of the U.S. In 2020, 41.8
Healthcare 52
52 
Curavit’s crystal ball – how will 2023 drive meaningful changes in clinical research
pharmaphorum
DECEMBER 22, 2022
The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways. Prediction 2: More clinical trial services will become remote, beyond just patient monitoring. An FDA Perspective on Decentralized Clinical Trials: Part 1. NPJ Digit Med. Chapman, J.
FDA 77
77 
Addressing the Polypharmacy Problem
PM360
JULY 13, 2023
Second, a patient may be on the right regimen, in which their five or more drugs are prescribed based on clinical evidence. 13 While primary care physicians can sometimes piece together a patient’s full treatment regimen, studies have found that patients often fail in reporting medications prescribed by other practitioners.
Prescription 52
52 
Let's personalize your content